相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gastroparesis: pharmacotherapy and cardiac risk
Per M. Hellstrom et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study
Henry P. Parkman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
The Metoclopramide Black Box Warning for Tardive Dyskinesia: Effect on Clinical Practice, Adverse Event Reporting, and Prescription Drug Lawsuits
Eli D. Ehrenpreis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Tardive and spontaneous dyskinesia incidence in the general population
Ray M. Merrill et al.
BMC PSYCHIATRY (2013)
Tardive dyskinesia syndromes: current concepts
Camila Catherine H. Aquino et al.
PARKINSONISM & RELATED DISORDERS (2013)
Zero-order release profile of metoclopramide hydrochloride sublingual tablet formulation
Randa Latif
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2013)
Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects
Roberto Bernardo-Escudero et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2012)
Clinical Response and Side Effects of Metoclopramide Associations With Clinical, Demographic, and Pharmacogenetic Parameters
Henry P. Parkman et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Spectrum of tardive syndromes: clinical recognition and management
Roongroj Bhidayasiri et al.
POSTGRADUATE MEDICAL JOURNAL (2011)
Review article: metoclopramide and tardive dyskinesia
A. S. Rao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Delayed Radionucleotide Gastric Emptying Studies Predict Morbidity in Diabetics With Symptoms of Gastroparesis
Brian Hyett et al.
GASTROENTEROLOGY (2009)
The Incidence, Prevalence, and Outcomes of Patients With Gastroparesis in Olmsted County, Minnesota, From 1996 to 2006
Hye-Kyung Jung et al.
GASTROENTEROLOGY (2009)
Metoclopramide, an increasingly recognized cause of tardive dyskinesia
Christopher Kenney et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Biowaiver monographs for immediate release solid oral dosage forms: Metoclopramide hydrochloride
A. G. Stosik et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood-brain barrier
Pascale Jolliet et al.
PHARMACOLOGICAL RESEARCH (2007)
Domperidone: Review of pharmacology and clinical applications in gastroenterology
Savio C. Reddymasu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Treatment of gastroparesis: a multidisciplinary clinical review
TL Abell et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Drug Insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide
PJ Pasricha et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Review article:: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
M Tonini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification
Nehal A. Kasim et al.
MOLECULAR PHARMACEUTICS (2004)
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
HP Parkman et al.
GASTROENTEROLOGY (2004)
Clinical implications of pharmacogenomics for tardive dyskinesia
DJ Muller et al.
PHARMACOGENOMICS JOURNAL (2004)
Relative hydrophobicity and lipophilicity of drugs measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. A simple model for predicting blood-brain distribution
N Gulyaeva et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6
Z Desta et al.
DRUG METABOLISM AND DISPOSITION (2002)
Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia
IC Lai et al.
NEUROPSYCHOBIOLOGY (2002)
Molecular effects of dopamine on striatal-projection pathways
CR Gerfen
TRENDS IN NEUROSCIENCES (2000)
Nationwide standardisation and evaluation of scintigraphic gastric emptying:: reference values and comparisons between subgroups in a multicentre trial
P Grybäck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
分享论文
